Project Grant R24OD035577
Award Date
9/16/24
Completion Date
8/31/28
Dollars Obligated
$630K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Aggregate Financial Assistance Data
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
This Project Grant award of $438,000 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the development of conditional animal models of mitochondrial DNA diseases at the University of Texas at Austin. The project aims to use CRISPR gene editing tools to introduce precise edits in the mitochondrial genome of zebrafish, enabling the creation of the first conditional animal model for mitochondrial disorders like mitochondrial...
This $999,996 Project Grant award, provided by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports fundamental research aimed at generating "designer mitochondria" for biotechnology, healthcare, and basic research applications. The key objectives are to identify the factors required for human mitochondrial DNA (mtDNA) replication and characterize the mechanisms underlying the species-specificity of this process. This work represents a critical step...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will provide $146,922 to the University of Southern California (USC) to conduct research aimed at purging mammalian cells of deleterious mutations in mitochondrial DNA (mtDNA). The research will utilize genetic and molecular biology tools, along with advanced sequencing techniques, to identify treatments that can selectively remove mtDNA mutations. This research has the potential to transform understanding...
This Project Grant award of $743,926 from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will develop a resource of rigorously validated, translatable zebrafish models of previously undiagnosed human genetic diseases. The project will analyze genetic variants obtained from patients with rare, undiagnosed diseases through collaboration with clinical research consortia, and then generate humanized zebrafish models using CRISPR/Cas9 technology....
This $773,479 Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to develop a novel CRISPR-Cas9 based mitochondrial gene editing system (MEDITORS) that can introduce, remove, and regulate heteroplasmy of the common MELAS mitochondrial DNA mutation (m.3243A>G) in human induced pluripotent stem cell-derived cardiomyocytes. The goal is to ascribe causal relationships between specific mitochondrial DNA...
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $607,682 to the Oklahoma Medical Research Foundation (OMRF) from July 2024 to June 2028. The project aims to develop scalable methods for rapid phenotyping and functional testing of genetic variants using zebrafish models. Specifically, the award will fund the creation of an 80-mutant knockout library and the optimization of CRISPR-based base editing...
The University of California, San Diego will receive $2,844,000 under a three-year Project Grant from the Department of Health and Human Services' National Institute of General Medical Sciences to develop tools and models to decode mitochondrial morphology dynamics and predict cell fate decisions. The grant funds research from September 2022 to August 2025 under the Biomedical Research and Research Training program (CFDA 93.859). Specifically, the University will expand its prototype...
This Project Grant award of $150,000 from the National Science Foundation's (NSF) Biological Sciences (CFDA 47.074) Federal Grant Program supports research at the University of South Alabama to enhance the natural repair mechanisms of mitochondrial DNA. The key objectives of this 4-year project are to re-engineer the mitochondrial localization signals of five DNA glycosylase enzymes to improve their targeting to mitochondria while preserving their nuclear localization. This novel computational...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $399,766 to the University of Kansas Center for Research Inc. and the University of California, Santa Barbara to conduct research on understanding the interplay between mitochondrial and nuclear genomes and their impact on mitochondrial dysfunction and age-related diseases. The key focus is leveraging the mitochondrial genomic variation observed in populations of threespine stickleback fish to...
This federal Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) provides $237,874 to the Van Andel Research Institute (VAI) from November 1, 2024 to April 30, 2028. The grant supports research to uncover how the mitochondrial acyl carrier protein (MTACP) regulates energy production in mitochondria, with the goal of providing a foundation for future therapeutic strategies targeting mitochondrial...